Methodology

Characteristics of Endoret®(prgf®) technology

Tubo de ensayo

  • It is simple as it requires just one centrifugation On the other hand, other technologies use several centrifugations, which can cause the nonspecific activation of platelets..
  • The volume of blood used is variable (from 9ml) and adequate for each application. Endoret®(prgf®) technology is the most efficient technology in the market to obtain plasma..
  • It is precise because it allows you to control the moment the plasma is activated..
  • It uses concentrations of growth factors within the therapeutic window for the stimulation of tissue regeneration as has been demonstrated in in-vitro research, in animals or in clinical trials. Other products use concentrations outside this window, obtaining unpredictable results.
  • 100% biocompatible, safe and versatile
  • It does not include leucocytes in its formulation, thus avoiding their proinflammatory effects.
  • Powerful bacteriostatic properties.

This section may describe clearances in countries other than the Unite States, and therefore may contain indications and information that are outside the scope of the FDA-cleared.

Are you interested in contacting us?

Contact